https://www.marketscreener.com/quote/stock/INNOCARE-PHARMA-LIMITED-105526513/news/InnoCare-Pharma-Announces-Dosing-of-First-Patient-in-Clinical-Study-of-the-Combination-of-SHP2-Inhib-46316474/?utm_source=telegram&utm_medium=social&utm_campaign=share